Nicotine Salts and Synthetic Nicotine: New Challenges for an Old Problem

• Autor(a) principal: Silva, André Luiz Oliveira da
• Data de Publicação: 2022
• Outros Autores: Moreira, Josino Costa
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Revista Brasileira de Cancerologia (Online)
• Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/2846
• topic: tabagismo; nicotina; sistemas eletrônicos de liberação de nicotina; abandono do hábito de fumar; controle e fiscalização de produtos derivados do tabaco; tobacco use disorder; nicotine; electronic nicotine delivery systems; smoking cessation; control and sanitary supervision of tobacco-derived products; tabaquismo; nicotina; sistemas electrónicos de liberación de nicotina; cese del hábito de fumar; control y fiscalización de productos derivados del tabaco

Smoking is recognized as a chronic disease caused by dependence on nicotine present in tobacco products. and is linked to a number of tobacco related diseases. In addition to this, it is considered a pediatric disease. In Brazil, treatment for smoking cessation since 2004 is offered at all levels of complexity by the National Health System (SUS), however the existing protocols internationally used seems to have significant limitations when used in populations like children and adolescents. Nicotine salts have a lower degree of irritation and impact in the throat and mouth caused by nicotine, enabling the use of higher concentrations of nicotine. Synthetic nicotine has shown itself to be more economically viable every day and there are already products on the market that use this form of nicotine, however few studies have been conducted to assess its health impacts. The new forms of nicotine and its synthetic form, associated with products with an attractive design, especially for the youngest, bring considerable technical challenges to health professionals, as effective protocols to treat nicotine dependence arising from these new forms of use are currently unknown.